Triggering typical nemaline myopathy with compound heterozygous nebulin mutations reveals myofilament structural changes as pathomechanism.
Johan LindqvistWeikang MaFrank LiYaeren HernandezJustin KolbBalazs KissPaola ToninoRobbert van der PijlEsmat KarimiHenry GongJosh StromZaynab HouraniJohn Edward SmithCoen OttenheijmThomas IrvingHenk L GranzierPublished in: Nature communications (2020)
Nebulin is a giant protein that winds around the actin filaments in the skeletal muscle sarcomere. Compound-heterozygous mutations in the nebulin gene (NEB) cause typical nemaline myopathy (NM), a muscle disorder characterized by muscle weakness with limited treatment options. We created a mouse model with a missense mutation p.Ser6366Ile and a deletion of NEB exon 55, the Compound-Het model that resembles typical NM. We show that Compound-Het mice are growth-retarded and have muscle weakness. Muscles have a reduced myofibrillar fractional-area and sarcomeres are disorganized, contain rod bodies, and have longer thin filaments. In contrast to nebulin-based severe NM where haplo-insufficiency is the disease driver, Compound-Het mice express normal amounts of nebulin. X-ray diffraction revealed that the actin filament is twisted with a larger radius, that tropomyosin and troponin behavior is altered, and that the myofilament spacing is increased. The unique disease mechanism of nebulin-based typical NM reveals novel therapeutic targets.
Keyphrases
- skeletal muscle
- photodynamic therapy
- early onset
- mouse model
- insulin resistance
- late onset
- high fat diet induced
- magnetic resonance
- type diabetes
- high resolution
- genome wide
- adipose tissue
- gene expression
- metabolic syndrome
- binding protein
- small molecule
- autism spectrum disorder
- magnetic resonance imaging
- cell migration
- muscular dystrophy
- protein protein
- crystal structure